Skip to main content
. Author manuscript; available in PMC: 2016 Jan 5.
Published in final edited form as: Circ Heart Fail. 2012 May 2;5(4):414–421. doi: 10.1161/CIRCHEARTFAILURE.111.964791

Table 1.

Baseline Characteristics

Characteristic Ischemic Nonischemic P Value
No. patients 5185 3358
Age, y 77.0±9.9 77.9±11.3 <0.001
Hypertension 2601 (50.2) 1475 (43.9) <0.001
Hyperlipidemia 1260 (24.3) 257 (7.7) <0.001
Diabetes 2020 (39.0) 981 (29.2) <0.001
Smoking history 1991 (38.4) 1096 (32.6) <0.001
Cerebrovascular disease 1012 (19.5) 485 (14.4) <0.001
Peripheral vascular disease 885 (17.1) 310 (9.2) <0.001
Dialysis 75 (1.4) 48 (1.4) 0.948
Chronic obstructive lung disease 978 (18.9) 575 (17.1) 0.042
Atrial fibrillation 1633 (31.5) 955 (28.4) 0.003
HFrEF HFpEF
No. patients 2448 1190
Age, y 74.6±10.4 77.9±9.8 <0.001
Hypertension 1187 (48.5) 667 (56.1) <0.001
Hyperlipidemia 583 (23.8) 178 (15.0) <0.001
Diabetes 926 (37.8) 384 (32.3) 0.001
Smoking history 1085 (44.3) 433 (36.4) <0.001
Cerebrovascular disease 398 (16.3) 207 (17.4) 0.388
Peripheral vascular disease 405 (16.5) 140 (11.8) <0.001
Dialysis 23 (0.9) 13 (1.1) 0.622
Chronic obstructive lung disease 381 (15.6) 225 (18.9) 0.001
Atrial fibrillation 690 (28.2) 448 (37.6) <0.001
Men Women
No. patients 4133 4410
Age, y 75.2±10.6 79.4±9.9 <0.001
Hypertension 1811 (43.8) 2265 (51.4) <0.001
Hyperlipidemia 843 (20.4) 674 (15.3) <0.001
Diabetes 1554 (37.6) 1447 (32.8) <0.001
Smoking history 2012 (48.7) 1075 (24.4) <0.001
Cerebrovascular disease 714 (17.3) 783 (17.8) 0.56
Peripheral vascular disease 737 (17.8) 458 (10.4) <0.001
Dialysis 70 (1.7) 53 (1.2) 0.056
Chronic obstructive lung disease 859 (20.8) 694 (15.7) <0.001
Atrial fibrillation 1238 (30.0) 1350 (30.6) 0.508

Data are presented as mean±SD or n (%). HFrEF indicates heart failure with reduced ejection fraction; HFpEF, heart failure with preserved ejection fraction.